Share this link via:
The past decade witnessed a significant increase in demand for bioinformatics services. Based on the report, the sector hosts more than 300 startup companies, and most were founded or funded by industry giants such as GE Healthcare, Novartis AG, and IBM Corp. Startups in life sciences now represent 60% of biotech companies worldwide. An increasing amount of biological research with the aid of cloud computing methods and the need for extensive software development considering the development of next-generation sequencing technology are some of the factors behind the expansion of the bioinformatics industry. Conventional pharmaceutical firms have also been trying to discover new therapeutic targets and expand their product portfolios by acquiring early-stage technology firms. Increased involvement of clinical research organizations (CROs) in clinical trials has resulted in the offering of bioinformatics services for biomarker assay validation and advisory. Expanded diagnostics and companies that offer rapid tests are also expected to boost reagent sales for molecular biology procedures.
The growth of new drugs and widening patient bases in the world are expected to boost the demand for bioinformatics services from pharma companies from $2 billion to more than $5.7 billion within five years, thereby fueling the bioinformatics industry.
Procedures become more sophisticated and new applications are found as new technology is developed. This can be observed in the history of computers, which were first mainly used for computation but today also have capabilities for communication, memory, and general-purpose programming. The same challenges now face the bioinformatics community. It is becoming an area more universally applied to the life sciences, rather than an area of specialist analysis work. As the ability of bioinformatics increases, one hopes it will become a part of mainstream research and ultimately lead to new discoveries.
Many funding agencies, such as the National Science Foundation (NSF) and the National Institute of Health (NIH), have started to accelerate their support of bioinformatics research to do this. Still continuing to provide universities and laboratories with sufficient money, this new money needs to be used to hire interdisciplinary researchers and reorganize the discipline. Nineteen percent of all institutions prefer computer science or statistics over life sciences because of the most recent NIH funds alone.
A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global Bioinformatics Market. On the basis of historic growth analysis and current scenario of Bioinformatics market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Bioinformatics market. This further helps users with their developmental strategy.
This report examines all the key factors influencing growth of global Bioinformatics market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Bioinformatics market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, pricing strategies, innovation possibilities and much more.
The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
As bioinformatics is becoming an essential part of various disciplines, such as medicine, agricultural biotechnology, and animal science, its application is extending to other sectors. In plant biology, bioinformatics is also extensively used to study better breeding methods, molecular genetics and genomics, and biosynthesis of secondary metabolites, among others. Medical informatics can make use of computers for research and the provision of patient care by healthcare organizations. Health professionals, information technologists, and scientists converge in medical informatics, which can assist with improved clinical practice, improved medication administration, and improved public health policy decisions. By its application to diagnosis and treatment, medical informatics has become an essential part of medicine, contributing to enhanced patient care services.
Medical informatics, also concerned with designing new electronic health records with the assistance of computer technology, has increased gradually in the bioinformatics industry in recent years, even though digitised medical records could pose greater privacy and confidentiality issues. Medical informatics is referred to as the use of computers in medicine for various tasks such as managing, analyzing, retrieving, storing, and distributing medical data.
The report also helps in understanding Global Bioinformatics Market dynamics, structure by analyzing the market segments, and project the Global Bioinformatics Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Bioinformatics Market make the report investor’s guide.
Eurofins Scientific (Luxembourg), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), Waters Corporation (US), DNASTAR (US), GENEWIZ (US) and BGI Group (China), NeoGenomics Laboratories (US), Waters Corporation (US), DNASTAR (US), Perkin Elmer, Inc. (US), GENEWIZ (US), Partek Incorporated (US), BGI Group (China), Fios Genomics (UK), SOPHiA Genetics (Switzerland), Biomax Informatics AG (Germany), and Source BioScience (UK) among others.
Most of the developed nations have embraced computer technology on a mass scale but developing nations are following developed countries and embracing electronic records rather than using conventional paper-based medical records owing to its potential of giving more security to medical data and speedy availability. Many healthcare facilities have begun adopting medical informatics which enables instant display of patient data that may prove helpful in emergency departments, intensive care and operating rooms so that doctors may obtain necessary information at a faster rate. It has helped them cut down medical mistakes by computerizing activities like drug dispensation and ordering material or inventory checking at hospitals. It is also utilized extensively in the operation and maintenance of laboratory information systems that offer simpler access to laboratory orders and records with test results.
The North America bioinformatics market is expected to register a healthy CAGR over the forecast period. The growth of R&D operations among biotechnology companies will be a key driver of the overall development of this region. For example, Pfizer Inc. recently made announcements regarding establishing its first innovation hub outside New York City in Cambridge and declared that one-third of its employees (approximately 3,000 scientists) would be based either in Europe by the end of this year or relocating to Cambridge. But with rising biotechnology activity in the area there is an increasing demand for professionals with specialized skillsets. In recent years, North American bioinformatics markets have seen increasing demand for equipment utilized for DNA sequencing and genotyping.
Asia-Pacific is one of the largest regional markets for bioinformatics. More than 50% of the world's market is found in North America, and merely 25% is in the Asia Pacific area. The region has mature economies such as China, Japan, and Australia, and the scientific research there is growing extensively. The reason is that the government has invested in research and development across a range of sectors, such as biotechnology, pharmaceuticals, and healthcare. The need for bioinformatics software programs in this field has grown due to the growth of funding for healthcare, which has opened new avenues for hospitals, diagnostic centers, and pharmaceutical companies.
The encouragement of translational research ventures like drug repositioning (bio isolation/remediation), biomarkers, and interpretation of functional genomics data is the major force behind the global application-specific bioinformatics market growth. The lead time required to advance compounds to manufacturing and the increasing research cost have necessitated computer-aided drug discovery technology increasingly.
The objective of the report is to present comprehensive analysis of Global Bioinformatics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Bioinformatics Market Report is also available for below Regions and Country Please Ask for that
Bioinformatics Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
20 Mar 2023
Intellectual Market Insights Research © 2026. All rights reserved.
